Ihara-gun, Japan

Akira Mada

This inventor holds 1 USPTO granted patent. Top assignee: Kowa Company Limited. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akira Mada: Innovator in Local Anesthetics

Introduction

Akira Mada is a notable inventor based in Ihara-gun, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of local anesthetics. His innovative approach has led to the creation of a unique formulation that enhances the effectiveness of pain relief.

Latest Patents

Mada holds a patent for a local anesthetic for external use. This formulation is prepared by blending an active ingredient selected from lidocaine, prilocaine, and pharmaceutically acceptable salts thereof. It also includes a percutaneous absorption accelerator, ethanol and/or isopropyl alcohol, and water. The blending ratio of ethanol and/or isopropyl alcohol to water is maintained between 0.5 to 1.2 by weight, with a pH range of 6.0 to 8.5. This innovative formulation aims to improve the efficacy of local anesthesia in external applications.

Career Highlights

Akira Mada is associated with Kowa Company Limited, where he has been instrumental in advancing research and development in anesthetic products. His work has contributed to the company's reputation as a leader in pharmaceutical innovations.

Collaborations

Mada collaborates with fellow inventor Toshio Inagi, working together to enhance the development of anesthetic formulations and other pharmaceutical products.

Conclusion

Akira Mada's contributions to the field of local anesthetics demonstrate his commitment to innovation and improving patient care. His patent reflects a significant advancement in the formulation of effective pain relief solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…